- Home
- RA vs IRMD Comparison
RA vs IRMD Comparison
Compare RA & IRMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RA
- IRMD
- Stock Information
- Founded
- RA 2016
- IRMD 1992
- Country
- RA United States
- IRMD United States
- Employees
- RA 1260
- IRMD N/A
- Industry
- RA Investment Managers
- IRMD Medical/Dental Instruments
- Sector
- RA Finance
- IRMD Health Care
- Exchange
- RA Nasdaq
- IRMD Nasdaq
- Market Cap
- RA 711.7M
- IRMD 756.5M
- IPO Year
- RA N/A
- IRMD 2014
- Fundamental
- Price
- RA $13.44
- IRMD $59.02
- Analyst Decision
- RA
- IRMD Strong Buy
- Analyst Count
- RA 0
- IRMD 1
- Target Price
- RA N/A
- IRMD $72.00
- AVG Volume (30 Days)
- RA 280.8K
- IRMD 65.0K
- Earning Date
- RA 01-01-0001
- IRMD 07-31-2025
- Dividend Yield
- RA 14.73%
- IRMD 1.15%
- EPS Growth
- RA N/A
- IRMD 10.72
- EPS
- RA N/A
- IRMD 1.55
- Revenue
- RA N/A
- IRMD $75,154,639.00
- Revenue This Year
- RA N/A
- IRMD $10.62
- Revenue Next Year
- RA N/A
- IRMD $9.69
- P/E Ratio
- RA N/A
- IRMD $38.08
- Revenue Growth
- RA N/A
- IRMD 11.04
- 52 Week Low
- RA $11.89
- IRMD $42.34
- 52 Week High
- RA $17.32
- IRMD $63.29
- Technical
- Relative Strength Index (RSI)
- RA 72.47
- IRMD 50.69
- Support Level
- RA $13.40
- IRMD $59.50
- Resistance Level
- RA $13.53
- IRMD $62.25
- Average True Range (ATR)
- RA 0.09
- IRMD 1.67
- MACD
- RA 0.05
- IRMD -0.27
- Stochastic Oscillator
- RA 86.37
- IRMD 32.00
About RA Brookfield Real Assets Income Fund Inc.
Brookfield Real Assets Income Fund Inc. is a diversified, closed-end management investment company. Its investment objective is to seek a high total return, through high current income and secondarily, through the growth of capital. The Fund seeks to achieve its investment objective by investing in the real asset class, which includes the following: Real Estate Securities; Infrastructure Securities; and Natural Resources Securities. The Firm manages separate accounts, registered funds, and opportunistic strategies for institutional and individual clients, including financial institutions, public and private pension plans, insurance companies, endowments and foundations, sovereign wealth funds, and high-net-worth investors.
About IRMD iRadimed Corporation
iRadimed Corp develops, manufactures, markets and distributes a Magnetic Resonance Imaging (MRI) compatible intravenous (IV) infusion pump system, and MRI compatible patient vital signs monitoring system, and accessories and services relating to them. The company provides a non-magnetic IV infusion pump system which is designed to be safe for use during MRI procedures. The MRI products of the company are sold to hospitals and acute care facilities in the United States and internationally. It generates majority revenue from United States.